Despite signs of crisis among science startups,many still think that biotech will create companies so powerful that they will ‘win the 21st centuryIt was midday on a Thursday at a gathering of science startups in San Francisco. The public market for biotechnology stock had dropped 25% in two months. The private sectors star startup, Theranos, or valued at $9bn,has begun to implode. The most popular food tech startup, Hampton Creek, or which is trying to reinvent mayonnaise,has reportedly stretched the truth of their science.
And yet there was no sign of peril on that sunny afternoon.
Continue reading...
Source: theguardian.com